Laura Pontiggia

Professor and Director of Academic Programs

Thomas Jefferson University

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Laura Pontiggia is a Professor and Director of Academic Programs at Thomas Jefferson University in the United States. Her research areas include nutrition-related side effects in cancer treatment, antiretroviral therapies for HIV, and optimizing antibiotic dosing in various infections. She has contributed to studies focusing on neurocognitive assessments in HIV treatment and the role of specific biomarkers in breast cancer. Dr. Pontiggia's work aims to enhance patient care and treatment outcomes across multiple health domains.

Articles (10)

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Jessica Adams

UNITED STATES

View details

Jonathan Deutsch

Professor

Drexel University

UNITED STATES

View details

James Hollands

Saint Joseph's University

UNITED STATES

View details

Islam Ghazi

Assistant Professor

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Laura Pontiggia

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

When Eating Becomes Torturous: Understanding Nutrition-Related Cancer Treatment Side Effects among Individuals with Cancer and Their Caregivers

Optimal vancomycin dose in the treatment of Clostridium difficile infection, antimicrobial stewardship initiative

Comparative effectiveness of antiretroviral drug classes for the treatment of HIV infection in patients with high viral loads: a multicentre retrospective cohort study

Refining interprofessional, outpatient transitions of care services to reduce hospital readmissions

Changes in neurocognitive assessment scores after initiating dolutegravir- versus elvitegravir-based antiretroviral therapy

Essential role of STAT5a in DCIS formation and invasion following estrogen treatment

Metabolic Complications Occur More Frequently in Older Patients Receiving Parenteral Nutrition

Impact of Daptomycin Minimum Inhibitory Concentration on Clinical Cure Rates for Vancomycin-Resistant Enterococcus Infections

Phosphorylated STAT3 (Tyr705) as a biomarker of response to pimozide treatment in triple-negative breast cancer

Development of CAPER peptides for the treatment of triple negative breast cancer

Collaborators (4)

Jessica Adams

Jonathan Deutsch

James Hollands

Islam Ghazi

Make your next move.